HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Ya Ma Selected Research

3,5,3',4',5'-pentahydroxy-stilbene

10/2008Resveratrol directly targets COX-2 to inhibit carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Ya Ma Research Topics

Disease

23Neoplasms (Cancer)
10/2020 - 01/2003
6Carcinogenesis
09/2014 - 01/2003
3Colonic Neoplasms (Colon Cancer)
10/2020 - 10/2008
3Skin Neoplasms (Skin Cancer)
09/2014 - 08/2005
2Melanoma (Melanoma, Malignant)
01/2020 - 08/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2014
2Inflammation (Inflammations)
01/2018 - 05/2008
1Colitis
10/2020
1AIDS-Related Complex (ARC)
10/2020
1Adenocarcinoma of Lung
01/2020
1Adenocarcinoma
11/2019
1Barrett Esophagus (Barrett's Esophagus)
11/2019
1Wounds and Injuries (Trauma)
01/2018
1Infections
01/2018
1Neoplasm Metastasis (Metastasis)
11/2017
1Esophageal Neoplasms (Esophageal Cancer)
05/2016
1Carcinoma (Carcinomatosis)
05/2016
1Genomic Instability
01/2011
1Lung Neoplasms (Lung Cancer)
05/2010
1Pain (Aches)
02/2009
1Glioblastoma (Glioblastoma Multiforme)
09/2008
1Colorectal Neoplasms (Colorectal Cancer)
07/2007
1Kidney Neoplasms (Kidney Cancer)
11/2006
1Breast Neoplasms (Breast Cancer)
09/2006
1Coffin-Lowry Syndrome (Syndrome, Coffin-Lowry)
07/2002

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2020 - 05/2005
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 07/2007
3Pharmaceutical PreparationsIBA
01/2020 - 09/2006
3Biological ProductsIBA
01/2018 - 01/2003
3TeaIBA
09/2014 - 03/2006
3AgarIBA
10/2008 - 03/2007
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2020 - 01/2018
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2010 - 03/2008
2Carrier Proteins (Binding Protein)IBA
05/2010 - 03/2007
2ResveratrolIBA
10/2008 - 04/2003
2CarcinogensIBA
05/2008 - 11/2006
2Epidermal Growth Factor (EGF)IBA
07/2007 - 04/2003
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2005 - 07/2005
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2020
1Lysine (L-Lysine)FDA Link
10/2020
1AzoxymethaneIBA
10/2020
1Dextran SulfateIBA
10/2020
1VemurafenibIBA
01/2020
1Aurora Kinase BIBA
01/2020
1melanopsinIBA
01/2020
1OpsinsIBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Urethane (Ethyl Carbamate)IBA
01/2020
1Thromboxane A2 (A2, Thromboxane)IBA
11/2019
1Messenger RNA (mRNA)IBA
11/2017
1Phenol (Carbolic Acid)FDA Link
05/2016
14- propionyloxy- 4- phenyl- N- methylpiperidineIBA
05/2016
1TubulinIBA
05/2016
1Therapeutic UsesIBA
05/2016
1Gefitinib (Iressa)FDA Link
10/2014
1Protein Kinase InhibitorsIBA
10/2014
1kaempferolIBA
09/2014
13-hydroxyflavoneIBA
09/2014
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
07/2012
1Histones (Histone)IBA
01/2011
1ras ProteinsIBA
05/2010
1ErbB Receptors (EGF Receptor)IBA
02/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2009
1Transient Receptor Potential ChannelsIBA
02/2009
13,5,3',4',5'-pentahydroxy-stilbeneIBA
10/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2008
1Small Interfering RNA (siRNA)IBA
09/2008
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2008
1Mitogen-Activated Protein KinasesIBA
07/2007
1Protein Kinases (Protein Kinase)IBA
07/2007
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
03/2007
1arseniteIBA
11/2006
1ArsenicIBA
11/2006
1Etoposide (VP 16)FDA LinkGeneric
09/2006
1CaspasesIBA
09/2006
1Glucose (Dextrose)FDA LinkGeneric
09/2006
1Endoplasmic Reticulum Chaperone BiPIBA
09/2006
1theaflavinIBA
03/2006
1CalciumIBA
09/2005
1Crystallins (Crystallin)IBA
09/2005
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
08/2005
1Protein SIBA
08/2005
1Cyclin-Dependent Kinase Inhibitor p16IBA
08/2005
1Caffeine (No Doz)FDA LinkGeneric
05/2004
1pifithrinIBA
07/2003
1Protein Isoforms (Isoforms)IBA
01/2003
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2003
1Phosphotransferases (Kinase)IBA
07/2002
1Serine (L-Serine)FDA Link
07/2002

Therapy/Procedure

5Therapeutics
10/2020 - 07/2003
3Chemoprevention
09/2014 - 01/2003
2Drug Therapy (Chemotherapy)
05/2016 - 10/2008
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2020
1Oral Administration
11/2006